These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15272862)

  • 21. Structure of the Yersinia enterocolitica type III secretion translocator chaperone SycD.
    Büttner CR; Sorg I; Cornelis GR; Heinz DW; Niemann HH
    J Mol Biol; 2008 Jan; 375(4):997-1012. PubMed ID: 18054956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A common structural motif in the binding of virulence factors to bacterial secretion chaperones.
    Lilic M; Vujanac M; Stebbins CE
    Mol Cell; 2006 Mar; 21(5):653-64. PubMed ID: 16507363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coiled-coils in type III secretion systems: structural flexibility, disorder and biological implications.
    Gazi AD; Charova SN; Panopoulos NJ; Kokkinidis M
    Cell Microbiol; 2009 May; 11(5):719-29. PubMed ID: 19215225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of the type III effector protein AvrPphF and its chaperone reveal residues required for plant pathogenesis.
    Singer AU; Desveaux D; Betts L; Chang JH; Nimchuk Z; Grant SR; Dangl JL; Sondek J
    Structure; 2004 Sep; 12(9):1669-81. PubMed ID: 15341731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bacterial injection kit: type III secretion systems.
    Mota LJ; Cornelis GR
    Ann Med; 2005; 37(4):234-49. PubMed ID: 16019722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Structure and function of the type III secretion system in pathogenic bacteria].
    Kuwae A; Abe A
    Tanpakushitsu Kakusan Koso; 2005 Jan; 50(1):20-8. PubMed ID: 15651413
    [No Abstract]   [Full Text] [Related]  

  • 27. Genome-wide analysis of host responses to the Pseudomonas aeruginosa type III secretion system yields synergistic effects.
    Ichikawa JK; English SB; Wolfgang MC; Jackson R; Butte AJ; Lory S
    Cell Microbiol; 2005 Nov; 7(11):1635-46. PubMed ID: 16207250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A conserved Hpa2 protein has lytic activity against the bacterial cell wall in phytopathogenic Xanthomonas oryzae.
    Zhang J; Wang X; Zhang Y; Zhang G; Wang J
    Appl Microbiol Biotechnol; 2008 Jun; 79(4):605-16. PubMed ID: 18431569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Port of entry--the type III secretion translocon.
    Büttner D; Bonas U
    Trends Microbiol; 2002 Apr; 10(4):186-92. PubMed ID: 11912026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of the Yersinia enterocolitica type III secretion chaperone SycT.
    Locher M; Lehnert B; Krauss K; Heesemann J; Groll M; Wilharm G
    J Biol Chem; 2005 Sep; 280(35):31149-55. PubMed ID: 16000312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells.
    Hayward RD; Cain RJ; McGhie EJ; Phillips N; Garner MJ; Koronakis V
    Mol Microbiol; 2005 May; 56(3):590-603. PubMed ID: 15819617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type III secretion system effector proteins: double agents in bacterial disease and plant defense.
    Alfano JR; Collmer A
    Annu Rev Phytopathol; 2004; 42():385-414. PubMed ID: 15283671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter.
    Charpentier X; Oswald E
    J Bacteriol; 2004 Aug; 186(16):5486-95. PubMed ID: 15292151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type III secretion chaperones of Pseudomonas syringae protect effectors from Lon-associated degradation.
    Losada LC; Hutcheson SW
    Mol Microbiol; 2005 Feb; 55(3):941-53. PubMed ID: 15661015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress in type III secretion system].
    Wang L; Wang YM; Yue JJ; Liang L; Huang PT
    Wei Sheng Wu Xue Bao; 2004 Dec; 44(6):840-4. PubMed ID: 16110974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural characterization of a type III secretion system filament protein in complex with its chaperone.
    Yip CK; Finlay BB; Strynadka NC
    Nat Struct Mol Biol; 2005 Jan; 12(1):75-81. PubMed ID: 15619638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide signal molecules and bacteriocins in Gram-negative bacteria: a genome-wide in silico screening for peptides containing a double-glycine leader sequence and their cognate transporters.
    Dirix G; Monsieurs P; Dombrecht B; Daniels R; Marchal K; Vanderleyden J; Michiels J
    Peptides; 2004 Sep; 25(9):1425-40. PubMed ID: 15374646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SseK1 and SseK2 are novel translocated proteins of Salmonella enterica serovar typhimurium.
    Kujat Choy SL; Boyle EC; Gal-Mor O; Goode DL; Valdez Y; Vallance BA; Finlay BB
    Infect Immun; 2004 Sep; 72(9):5115-25. PubMed ID: 15322005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The type VI secretion system: translocation of effectors and effector-domains.
    Pukatzki S; McAuley SB; Miyata ST
    Curr Opin Microbiol; 2009 Feb; 12(1):11-7. PubMed ID: 19162533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The X-ray structure of the type II secretion system complex formed by the N-terminal domain of EpsE and the cytoplasmic domain of EpsL of Vibrio cholerae.
    Abendroth J; Murphy P; Sandkvist M; Bagdasarian M; Hol WG
    J Mol Biol; 2005 May; 348(4):845-55. PubMed ID: 15843017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.